Tianjin Ringpu Bio-Technology Co Ltd operates within the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Tianjin Ringpu Bio-Technology Co Ltd with three other
companies in this sector in China:
Beijing SL Pharmaceutical Co Ltd
sales of 1.01 billion Chinese Renmimbi [US$156.95 million]
of which 98%
was Pharmaceuticals Industry),
Changsheng Bio-technology Co Ltd
(1.02 billion Chinese Renmimbi [US$158.20 million]
of which 100%
was Vaccine Sales), and
Boya Bio-pharmaceutical Group Co Ltd
(946.57 million Chinese Renmimbi [US$147.12 million]
of which 56%
was Blood Plasma).
During the year ended December of 2016, sales at
Tianjin Ringpu Bio-Technology Co Ltd were 969.68 million Chinese Renmimbi (US$150.71 million).
increase of 22.4%
versus 2015, when the company's sales were 792.32 million Chinese Renmimbi.
Sales of Other Operation saw an increase
41.3% in 2016, from
15.97 million Chinese Renmimbi to 22.57 million Chinese Renmimbi.